Drugs / Ferric Bepectate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07687784 | Dec 2026 → Jun 2028 expected | iron deficiency anemia | AFT Pharmaceuticals, Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ferric Bepectate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07687784 ↗ |
| Route | Intravenous | “new i.v. iron formulation” NCT07687784 ↗ |